Baldwin Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$874K Sell
2,413
-227
-9% -$77.7K 0.06% 117
2026
Q1
$929K Sell
2,640
-481
-15% -$171K 0.07% 108
2025
Q4
$1.02M Sell
3,121
-66
-2% -$20.9K 0.07% 113
2025
Q3
$899K Sell
3,187
-53
-2% -$15.4K 0.06% 113
2025
Q2
$905K Sell
3,240
-678
-17% -$192K 0.06% 105
2025
Q1
$1.22M Sell
3,918
-230
-6% -$67.9K 0.09% 93
2024
Q4
$1.08M Sell
4,148
-1,282
-24% -$380K 0.07% 103
2024
Q3
$1.75M Buy
5,430
+1,708
+46% +$559K 0.12% 94
2024
Q2
$1.16M Sell
3,722
-121
-3% -$35.5K 0.09% 94
2024
Q1
$1.09M Sell
3,843
-241
-6% -$70.5K 0.08% 106
2023
Q4
$1.18M Sell
4,084
-48
-1% -$13.1K 0.09% 100
2023
Q3
$1.11M Sell
4,132
-51
-1% -$12.7K 0.1% 105
2023
Q2
$929K Sell
4,183
-374
-8% -$86.8K 0.08% 114
2023
Q1
$1.1M Hold
4,557
0.1% 107
2022
Q4
$1.2M Buy
4,557
+3,117
+216% +$836K 0.11% 107
2022
Q3
$325K Sell
1,440
-140
-9% -$33.9K 0.04% 134
2022
Q2
$384K Sell
1,580
-630
-29% -$154K 0.05% 128
2022
Q1
$534K Sell
2,210
-1,262
-36% -$290K 0.06% 112
2021
Q4
$781K Buy
3,472
+342
+11% +$72.2K 0.08% 91
2021
Q3
$666K Sell
3,130
-13,197
-81% -$3.04M 0.07% 92
2021
Q2
$3.98M Sell
16,327
-40,466
-71% -$9.95M 0.43% 48
2021
Q1
$14.1M Sell
56,793
-991
-2% -$236K 1.68% 21
2020
Q4
$13.3M Sell
57,784
-5,049
-8% -$1.16M 1.67% 22
2020
Q3
$16M Sell
62,833
-920
-1% -$228K 2.18% 12
2020
Q2
$15M Buy
63,753
+183
+0.3% +$41.8K 2.21% 12
2020
Q1
$12.9M Buy
63,570
+2,329
+4% +$509K 2.26% 14
2019
Q4
$14.8M Sell
61,241
-625
-1% -$138K 2.06% 14
2019
Q3
$12M Sell
61,866
-4,187
-6% -$804K 1.8% 19
2019
Q2
$12.2M Sell
66,053
-2,041
-3% -$365K 1.79% 17
2019
Q1
$12.9M Sell
68,094
-3,687
-5% -$704K 1.93% 15
2018
Q4
$14M Buy
71,781
+346
+0.5% +$67.5K 2.34% 11
2018
Q3
$14.8M Buy
71,435
+5,464
+8% +$1.08M 2.07% 11
2018
Q2
$12.2M Buy
65,971
+293
+0.4% +$51.8K 1.89% 16
2018
Q1
$11.2M Sell
65,678
-10,076
-13% -$1.85M 1.81% 16
2017
Q4
$13.2M Buy
75,754
+447
+0.6% +$79.1K 2.05% 12
2017
Q3
$14M Sell
75,307
-3,615
-5% -$641K 2.26% 12
2017
Q2
$13.6M Sell
78,922
-2,160
-3% -$351K 2.19% 13
2017
Q1
$13.3M Buy
81,082
+11,291
+16% +$1.88M 2.19% 11
2016
Q4
$10.2M Buy
69,791
+3,780
+6% +$569K 1.84% 21
2016
Q3
$11M Buy
66,011
+2,085
+3% +$353K 2% 18
2016
Q2
$9.73M Sell
63,926
-9,764
-13% -$1.52M 2% 15
2016
Q1
$11M Buy
73,690
+6,867
+10% +$1.02M 1.98% 12
2015
Q4
$10.8M Sell
66,823
-750
-1% -$118K 1.77% 13
2015
Q3
$9.35M Buy
67,573
+3,303
+5% +$521K 1.58% 18
2015
Q2
$9.87M Buy
64,270
+4,352
+7% +$697K 1.46% 21
2015
Q1
$9.58M Sell
59,918
-9,485
-14% -$1.49M 1.41% 26
2014
Q4
$11.1M Sell
69,403
-640
-0.9% -$99.7K 1.6% 20
2014
Q3
$9.84M Buy
70,043
+1,414
+2% +$185K 1.4% 22
2014
Q2
$8.12M Sell
68,629
-16,007
-19% -$1.85M 1.21% 26
2014
Q1
$10.4M Buy
84,636
+154
+0.2% +$18.7K 1.68% 15
2013
Q4
$9.64M Buy
84,482
+3,859
+5% +$439K 1.55% 14
2013
Q3
$9.02M Sell
80,623
-64
-0.1% -$6.94K 1.65% 15
2013
Q2
$7.96M Buy
+80,687
New +$8.37M 1.57% 17

Other funds holding AMGN

Baldwin Wealth Partners's AMGN Position: Q2 2026 in Review

Baldwin Wealth Partners reduced its Amgen (AMGN) stake by 8.6% in Q2 2026, selling an estimated $77.7K and leaving 2,413 shares worth $874K. The position accounts for 0.06% of the portfolio, ranked #117.

Baldwin Wealth Partners first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $16M in Q3 2020. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Baldwin Wealth Partners held 2,413 shares of Amgen worth $874K as of Q2 2026.
  • Baldwin Wealth Partners sold 227 Amgen shares in Q2 2026, an estimated $77.7K.
  • Amgen made up 0.06% of Baldwin Wealth Partners's portfolio in Q2 2026, its #117 holding.
  • Baldwin Wealth Partners first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Baldwin Wealth Partners's Amgen position peaked at $16M in Q3 2020.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Baldwin Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.